Stéphane Desgranges

Anisamide-targeted cyclodextrin nanoparticles for siRNA delivery to prostate tumours in mice

Jianfeng Guo, Julien Ogier, Stéphane Desgranges et al. · Biomaterials · 2012 · 127 citations

Nanomedicine, Drug Targeting, Nanotherapeutics +10

A click chemistry route to 2-functionalised PEGylated and cationic β-cyclodextrins: co-formulation opportunities for siRNA delivery

Aoife O’Mahony, Julien Ogier, Stéphane Desgranges et al. · Organic & Biomolecular Chemistry · 2012 · 70 citations

Nanoparticles, Nanotherapeutics, Engineering +19

Perfluorocarbon nanodroplets stabilized by fluorinated surfactants: characterization and potentiality as theranostic agents

Ksenia Astafyeva, Lucie Somaglino, Stéphane Desgranges et al. · Journal of Materials Chemistry B · 2015 · 51 citations · Full text

In Vitro Investigations of the Efficacy of Cyclodextrin-siRNA Complexes Modified with Lipid-PEG-Octaarginine: Towards a Formulation Strategy for Non-viral Neuronal siRNA Delivery

Aoife O’Mahony, Stéphane Desgranges, Julien Ogier et al. · Pharmaceutical Research · 2012 · 41 citations

Cell-based Drug Delivery, Nanomedicine, Engineering +10

β-Lactam-host defence peptide conjugates as antibiotic prodrug candidates targeting resistant bacteria

Stéphane Desgranges, Carol C. Ruddle, Liam P. Burke et al. · RSC Advances · 2012 · 34 citations

Peptide Engineering, Antibiotic Prodrug Candidates, Peptide Science +23